TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.260
-0.050 (-3.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $75.73 million as of April 29, 2026. Its market cap has increased by 7.92% in one year.
Market Cap
75.73M
Enterprise Value
17.46M
1-Year Change
7.92%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $75.73M, a decrease of -78.91%. That is a compound annual growth rate of -27.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 75.73M | 33.45% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 78.15M |
| Alterity Therapeutics | 78.00M |
| aTyr Pharma | 77.81M |
| XBiotech | 77.44M |
| MAIA Biotechnology | 75.84M |
| ImmuCell | 75.81M |
| PMV Pharmaceuticals | 75.73M |
| Filana Therapeutics | 75.36M |